CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY

David Laharie  1     Corey A Siegel  2     Karen Samaan  3     Deborah Fisher  3     Nathan Morris  3     Isabel Redondo  3     Parambir Singh Dulai  4     Vipul Jairath  5     Javier Gisbert  6     Matsuoka Katsuyoshi  7    
1 CHU de Bordeaux Hopital Haut-Leveque Dept. de Gastroenterologie, Pessac cedex, France
2 Dartmouth-Hitchcock Medical Center, Lebanon, United States
3 Eli Lilly and Company, Indianapolis, United States
4 Northwestern University, Chicago, United States
5 Western University, London, Canada
6 Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa and CIBEREHD, Madrid, Spain
7 Toho University Sakura Medical Center, Sakura, Japan

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing